检索

期
标题
作者
卷 23, 编号 1 (2021)
Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review
Menshikov K., Sultanbaev A., Akhmetgareeva K., Lipatov D.
PDF
(Rus)
卷 22, 编号 4 (2020)
Multiple myeloma
Mendeleeva L., Votiakova O., Rekhtina I., Osmanov E., Poddubnaya I., Grivtsova L., Falaleeva N., Baikov V., Kovrigina A., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
PDF
(Rus)
卷 20, 编号 2 (2018)
The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan
Berdimyradova M., Khadjiev S., Khommadova D., Polatova G., Kakajanova A., Batyrov C., Penayev D., Agayeva B., Annaberdiyeva G.
PDF
(Rus)
卷 19, 编号 2 (2017)
The treatment of patients with advanced lung cancer associated with EGFR mutation
Bolotina L.
PDF
(Rus)
卷 18, 编号 1 (2016)
The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options
Artamonova E., Manzyuk L.
PDF
(Rus)
卷 17, 编号 1 (2015)
Radiation-induced lung injury in breast cancer patients after breast conservation therapy
Trofimova O., Tkachev S., Ivanov S., Utkina V., Cheban O., Glebovskaya V.
卷 16, 编号 3 (2014)
Personalized approach to HER2-positive advanced breast cancertherapy
Stenina M.
卷 15, 编号 2 (2013)
Surgical stading local – cervical cancer incidence
Kargopolova M., Maximov S., Berlev I., Boyarkina M., Meshkova I., Khadzhimba A., Novikov S., Krzhivitsky P., Ponomareva O., Urmancheeva A., Ivanzov A., Guseynov K., Vishinskaya E., Matveeva N.
卷 23, 编号 3 (2021)
Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation
Gorenkova L., Belousova I., Kravchenko S., Kovrigina A., Sidorova Y., Ryzhikova N., Lepik E., Shneyder T.
PDF
(Rus)
卷 23, 编号 1 (2021)
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
Ignatova A.
PDF
(Rus)
卷 22, 编号 3 (2020)
Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up
Ognerubov N., Antipova T., Gumareva G.
PDF
(Rus)
卷 22, 编号 2 (2020)
Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience
Kolyadina I., Ganshina I., Kuzmicheva S., Tekeeva A., Kolokolov J., Volkonskii M., Poddubnaya I.
PDF
(Rus) PDF
(Eng)
卷 20, 编号 1 (2018)
Dermatomyositis and polymyositis in breast cancer patients: a case reports
Ganshina I., Zhukova L., Burnevitch E., Gordeeva O., Kondratieva O.
PDF
(Rus)
卷 19, 编号 1 (2017)
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Ryazhenov V.
PDF
(Rus)
卷 17, 编号 3 (2015)
Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer
Knyazev R., Poddubnaya I., Barinov V., Bokin I.
卷 16, 编号 3 (2014)
Vulvar Langerhans cell histiocytosis: case report
Poddubnaya I., Razumova E., Kizhaev Y., Ukolova E., Teterin K.
卷 16, 编号 1 (2014)
Radiation therapy as an independent method of treatment in case of carcinoma of floor of mouth
Garbuzov M.
卷 16, 编号 2 (2014)
Angiogenesis as a target for cancer therapy
Imyanitov E.
卷 15, 编号 2 (2013)
Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases
Sekacheva M., Bagmet N., Polishchuk L., Glazova O., Zaklyazminskaya E., Skripenko O.
101 - 119 的 119 信息 << < 1 2 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##